American Society of Hirudotherapy

Patellar Tendinopathy (Jumper's Knee, Investigational)

Investigational adjunct for chronic patellar tendinopathy (Blazina stage II-III); eccentric loading and heavy slow resistance training remain primary.

Tier C — InvestigationalInvestigational: Limited human evidence exists (small trials, case series, or pilot studies). Use is investigational and should be considered carefully under clinician guidance.Last Updated: November 10, 2026 · ASH Editorial · based on the books

Patient Summary

Is this FDA-cleared for this use?
Not FDA-cleared for patellar tendinopathy. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.
What evidence exists?
Tier C (investigational). No clinical study or case report of leech therapy for patellar tendinopathy was identified. Patellar tendinopathy (jumper's knee) responds best to load management plus a progressive eccentric or heavy slow-resistance training program over 12+ weeks (the strongest RCT support for any tendinopathy). Adjunctive options with some evidence include extracorporeal shock-wave therapy (ESWT), PRP injection, and (for refractory cases) ultrasound-guided needling or surgical excision of degenerative tissue. Corticosteroid injection is generally avoided in patellar tendinopathy because of rupture risk.
Main risks
  • Bleeding from each bite site for 6 to 24 hours after detachment
  • Bruising over the anterior knee for 5 to 10 days
  • Local skin or, rarely, Aeromonas hydrophila infection
  • Allergic reaction to leech saliva (uncommon)
  • Risk if placed too close to the patellar tendon itself - direct trauma may precipitate rupture
  • Septic prepatellar bursitis if a contaminated bite penetrates near the prepatellar bursa
  • Delay of evidence-based heavy slow-resistance training - the highest-evidence intervention
Who should not consider this
  • Patients with suspected partial or complete patellar tendon rupture (surgical evaluation)
  • Patients with patellofemoral pain syndrome, plica syndrome, or fat pad impingement misdiagnosed as tendinopathy
  • Patients with recent corticosteroid injection at the site (within 4 weeks)
  • Patients who have not completed at least 12 weeks of progressive eccentric or heavy slow-resistance training
  • Patients on anticoagulants, with hemophilia, or with anemia
  • Patients in active high-load training without scheduled rest
  • Patients with active dermatitis or broken skin over the anterior knee
What to ask your clinician
  • Have I had ultrasound or MRI to characterize the tendon and rule out partial or complete tear?
  • Have we ruled out patellofemoral pain, plica syndrome, or fat pad impingement as alternatives?
  • Have I completed a structured 12-week progressive eccentric or heavy slow-resistance training program?
  • Have I tried ESWT or PRP, and what is their evidence vs. this investigational option?
  • Where exactly will leeches be placed - confirm placement is adjacent to (NOT directly on) the patellar tendon?
  • What is the practitioner's plan if symptoms do not improve after 2 to 3 sessions?
  • What is the Aeromonas-prevention protocol?
When to seek urgent care
  • Sudden pop, severe pain, and inability to extend the knee (possible patellar tendon rupture - surgical emergency)
  • Acute severe knee swelling with warmth (possible septic bursitis or hemarthrosis)
  • Sudden patella migration upward (suggests tendon rupture)
  • Calf swelling, redness, or warmth (possible DVT)
  • Bleeding from a bite site lasting more than 24 hours
  • Fever, chills, or spreading redness at the bite site
  • Hives, facial or throat swelling, or breathing difficulty

What this does NOT mean

  • This is not FDA-cleared for patellar tendinopathy.
  • No controlled trials support efficacy; placebo response is high in chronic tendinopathy.
  • It does not replace heavy slow-resistance training, which has the strongest RCT support.
  • It does not address partial or complete tendon rupture, which is a surgical emergency.
  • Direct trauma to the tendon may precipitate rupture - placement must be adjacent, not over the tendon.

Clinical Profile

Category
Musculoskeletal
ICD-10
M76.50
Safety tier
Medium

Evidence Summary

Patellar tendinopathy (jumper's knee) is a chronic insertional or mid-tendon degenerative process most common in jumping athletes. Evidence-based management is single-leg decline eccentric squat protocols, heavy slow resistance training, and selective extracorporeal shock-wave therapy. PRP injection has mixed evidence. No clinical study or case report of hirudotherapy for patellar tendinopathy was identified in PubMed, Europe PMC or ClinicalTrials.gov (searched October 2026). The related reports found concern chronic post-traumatic soft-tissue injuries (tendons, ligaments, fasciae) in general (a Russian conference report of 43 patients summarized by Baskova and Isakhanyan, 2004) or another tendon site, lateral epicondylitis (a randomized trial of 40 patients, Bäcker et al., 2011). Any use is investigational and mechanistic only. Hirudotherapy as a primary intervention is inappropriate, and exercise rehabilitation must continue throughout.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: where the society's reference books describe a protocol, it is shown in the clinician view — switch the audience selector in the top bar to “Clinician”.)

Contraindications

  • Hemophilia or another bleeding disorder
  • Taking anticoagulants (blood thinners such as warfarin or heparin)
  • Anemia or suppressed blood formation
  • Low blood pressure, shock, collapse or fainting
  • Severe wasting (cachexia)
  • Intolerance of leeches or a history of severe allergic reactions
  • Pregnancy
  • Stomach or duodenal ulcer, erosive gastritis
  • Acute infectious disease or high fever
  • Severe unstable illness, markedly weakened immunity (for example during chemotherapy) or HIV infection
  • Drinking alcohol at the time of treatment
  • No consent from the patient
  • Tendon partial or complete tear (MRI confirmation needed)
  • Osgood-Schlatter or Sinding-Larsen-Johansson disease (skeletally immature)
  • Patellofemoral instability or maltracking as primary diagnosis
  • Discontinuation of rehabilitation program

Related Conditions

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.